Healthcare Compliance8 min read
Corporate Practice of Medicine: What Operators Need to Know in 2026
California's CPOM doctrine is being tested by new investor structures. Here is where the line actually sits.
The corporate practice of medicine doctrine bars unlicensed entities from owning or controlling clinical practice in California. In 2026, aggressive MSO structures are drawing renewed scrutiny from both the Attorney General and the Medical Board.
This post explains the doctrine, the classic MSO/PC split, and the specific control provisions most likely to draw enforcement attention today.
If you are structuring a platform investment in a medical group, the diligence questions have changed. We walk through the ones we now ask on every deal.
Disclaimer: This article is for general information only and is not legal advice. Every case turns on its own facts. Speak with a qualified California attorney about your specific situation.